***Currently accepting PhD students and Post Doctoral Fellows***
Background
The Respiratory Evaluation Sciences Program (RESP) is a comprehensive epidemiology, health outcomes, and health economics program focused on chronic respiratory diseases (namely asthma and chronic obstructive pulmonary disease [COPD]]).
The goal of the RESP program is improving patient outcomes and the efficiency of health care delivery in respiratory diseases through evidence-informed decision making at all levels of care.
RESP has a dual focus around two themes:
Theme 1, Burden of Disease and Observational Effectiveness Research
Using population-based health administrative data and other data sources, we estimate burden of lung disease, gaps in care, and ‘real world’ effectiveness of treatments.
Theme 2, Evaluation
Using state-of-the-art mathematical decision-analytic modeling techniques, we translate the evidence on the burden of diseases and impact of interventions, programs, and policies into actionable messages on cost-effectiveness (what option provides the best value for money?).
RESP is hosted within UBC Faculty of Pharmaceutical Sciences. Our partners include UBC Division of Respiratory Medicine, and Centre for Clinical Epidemiology and Evaluation
Our research has been funded by peer-reviewed grants from multiple institutions, including
|
|
|
|
|
